1 lpc support seminars vascular risk assessment. 2 introductions… alastair buxton head of nhs...
TRANSCRIPT
1
LPC Support Seminars
Vascular Risk Assessment
2
Introductions…
Alastair BuxtonHead of NHS Services
Mike Dent Head of Finance
Mike King Head of LPC and Contractor Support
3
Today's objectives• A background briefing on vascular disease
and clinical risk factors
• A description of the policy, the government programme and the service details
• Learning from examples of current pharmacy vascular risk services
• How to prepare and cost a compelling bid
4
Today's objectives
• Why community pharmacy should be commissioned
• How to sell into PCTs
• Securing contractor motivation and engagement
• Pricing the service looking at costs, market potential and service value
5
VRA overview
6
VRA – where did it all start?
• Diabetes, Heart Disease and Stroke (DHDS) Pilot Prevention Project - screening for type 2 diabetes
• ‘Vascular syndrome’ tackle risk factors
• National Screening Committee decision 2005
7
Gordon Brown announcement
...there will soon be check-ups on offer to monitor for heart disease, strokes, diabetes and kidney disease - conditions which affect the lives of 6.2 million people, cause 200,000 deaths each year and account for a fifth of all hospital admissions.
Jan 2008
• Putting prevention first March 2008 Vascular checks
8
VRA features in:
• Next Stage Review
• High Quality Care for All
• Our Vision for Primary and Community Care
• Pharmacy White Paper
9
Underpinned by:
• Coronary Heart Disease NSF
• Diabetes NSF
• Renal Disease NSF
• National Stroke Strategy
10
It can help with...
• reducing health inequalities (Public Service Agreement 18.2)
• improving life expectancy (Public Service Agreement 18.1)
• reducing mortality from circulatory diseases (SR 2004 Public Service Agreement 1.1 and 6.1)
• All DH and Local Area Agreement priority areas
11
Vital signs• Vascular risk score (VSC23) is a Tier 3 indicator in the
NHS Operating Framework Vital Signs 2008/09• The VRA programme will also contribute to a number of
improving health and reducing health inequality vital signs, such as:– the all-age all-cause mortality rate per 100,000 population;– the cardiovascular disease (CVD) mortality rate among
people under 75 years of age;– implementation of the Stroke Strategy;– smoking prevalence among people aged 16 or over in
routine and manual groups;– healthy life expectancy at age 65; and– the proportion of people where health affects the
amount/type of work they do.
12
The aim of the VRA programme
• To offer a straightforward risk assessment for diseases affecting the vascular system, including diabetes and chronic kidney disease, to everyone over 40 years (up to 74 years)
• Prevent 1,600 heart attacks and strokes a year• Save at least 650 lives a year• To reduce premature death from vascular
conditions including CHD, CKD, DM, stroke, TIA and PAD
13
The vascular checks programme
• Starts April 2009
• PCTs must ’show some evidence of participation’ with the programme during 2009
• Gradual increase in activity (Spearheads likely to lead)
• £250m cost phased in over 5 years
14
The VRA service
• Determine a person’s ’risk’ of developing a number of chronic conditions which affect the vascular system
– Coronary heart disease (heart attacks and angina);– Stroke;– Diabetes; and– Kidney Disease
• All linked by a common set of risk factors:– obesity, physical inactivity, smoking– high blood pressure, disordered blood lipid levels
(dyslipidaemia)– impaired glucose regulation (higher than normal blood
glucose levels, but not as high as in diabetes)
15
The overall approach
16
The VRA process
17
Stage 1 - Identification
• National Call and recall system• Local call and recall• Opportunistic approach
• Likely initial PCT approach?
18
Risk assessment Risk Management
RECALL
Cholesterol test
Smoking status
Physical activity
Body Mass Index
Age
Gender
Ethnicity
Diabetes filter
BP Measure
Statins prescription offered*
Exercise on prescription or other physical activity intervention
NHS stop smoking services referral
Weight management on referral
Vascular Checks Programme
Family history
EX
ITH
igh Risk
annual
reviews
RiskAssessment
EX
IT
Hypertension register
EX
IT
Diabete
s register
EX
IT
CK
D
register
^People recalled to separate appointments for diagnosis
Anti-hypertensives prescription *
Serum Creatinine^
Assessment for hypertension^
IFG/IGT lifestyle management advice
Oral Glucose Tolerance test^
DM
High
Blood sugar test
Raised blood pressure
IFG/IGT
If at risk
eGFR Low
Communication of risk
Sign post or refer to lifestyleinterventions
All to be undertaken by GP Practice Team
Initi
ally
, PC
Ts
deci
de w
hich
peo
ple
to c
all f
irst
and
w
here
the
che
cks
can
be a
cces
sed
(e.g
. Gen
eral
P
ract
ice,
pha
rmac
y et
c) b
eari
ng in
min
d th
e ne
ed to
ta
ckle
hea
lth in
equa
litie
s.
Key:
DM: Diabetes Mellitus
eGFR: estimated Glomerular Filtration Rate
IFG: Impaired Fasting Glucose
IGT: Impaired Glucose Tolerance
Behaviour change tool e.g. Mid Life LifeCheck
If CVD risk assessed as >20%
If blood sugar high
*or professionals with suitable patient information and prescribing rights
CKD assessment
19
Stage 2 – risk assessment
• Primary Care Framework
• PSNC service specification
20
Stage 3 - Intervention
• Basic advice to all• Impaired Glucose Tolerance (IGT) lifestyle
intervention• Pharmacological interventions• Exercise chat• Stop Smoking services• Diabetes management• Weight loss programmes
21
VRA – issues for providers
• Consultation facilities– Hand washing– Visual privacy– IT– Storage space
• POCT equipment– Effective procurement– Quality Assurance– Operator training– DH accreditation system
22
VRA – issues for providers
• SOPs (DH)• Clinical waste disposal• Infection control – processes and premises• Protective equipment• Needle stick protocol• Hepatitis B vaccination• Skill mix and competencies• Training – CPPE etc.
23
VRA – issues for providers
• IT and data transfer• Risk engines• Service outcomes (PROMs)• Audit and review• Patient satisfaction assessment• Marketing
– Social marketing– Link to Essential services– Reduce your risk campaign / brand image
24
Key reading
25
Still to come from DH
• SOPs and guidance on thresholds• Read/SNOMED CT codes for Minimum data set • Diabetes element of VRA• Call and recall system • Guidance on risk engine• Marketing programme / Branding • PCT performance management• Guidance on monitoring of providers
26
Pharmacy examples of VRA
27
Islington PCT
• 11 pharmacies in deprived areas
• Launched August 2008
• Assessed 1000 patients within 6 weeks
28
Birmingham PCTs – Heart MOT
• Opportunistic approach:– Nearly 900 patients screened– 49% referred to GP– 27% referred due to high CVD risk 82% male 18%
female– High level of uptake in deprived areas with low male
life expectancy
29
Birmingham PCTs – Heart MOT• Mass screening events using GP records based call
system:– On average 70 to 80% attendance rate if appointment
confirmed by phone– Over 9,500 males over the age of 40 have been screened– 65% of patients were referred
• 30% identified with elevated BP• 35% identified with elevated cholesterol• 18% identified with elevated blood glucose• 36% identified as having a high CVD risk
– 99% satisfied with appointments, with the tests and the explanations given
– 98% would recommend the service to a friend– 75% had a wait of less than 30 minutes– 76% ‘plan to make changes’ as a result of the clinic
30
Table discussion
a)Who are the competitors and what strengths and weaknesses do they have?
b) Why use community pharmacy? What are our strengths and weaknesses?
31
Preparing the bidStep 1 - LPC decision to investigate the provision of a VRA service
32
General guidance
• LPC Briefing – How to develop a successful service proposal
• Less need to sell the requirement for VRA as it is a national priority
33
Step 1 - LPC decision to investigate the provision of a VRA service • General assessment:
– The ability of pharmacy contractors to effectively deliver the service
– The willingness of contractors to provide the service (template survey)
– The risk of non-participation in the VRA service– Potential or pre-existing competitors
34
Step 2 - Identify and approach local stakeholders• Gathering information and garnering support
– LMC / GPs– Other healthcare professionals– Local patient groups– PCT staff:
• Director of Commissioning;• Director of Public Health;• Director of Primary Care;• Medical Director;• Pharmacy commissioning manager; and• Head of Pharmacy/Medicines Management
– Identify a PCT champion and the lead commissioner
35
Step 2 - Identify and approach local stakeholders• Use an informal chat with the PCT to obtain
background information:– How much of a priority is VRA for the PCT? – Does VRA feature in the Pharmaceutical Needs
Assessment or the Joint Strategic Needs Assessment?– What are the locally agreed vital signs for your PCT – is
VRA or a linked vital sign mentioned?– How will the service be commissioned? Will it be an ‘any
willing provider’ approach?– Is there an agreed service specification available?– What are the main targets set for the service?– How will outcomes be measured?– What role do they see for pharmacy in the delivery of the
service?– What is the timetable for commissioning and roll out?
36
Step 3 – Competitor assessment• Likely competitors:
– GP practices– Nurse led screening service providers, e.g. Innovex– NHS health trainers– Third sector (charitable) organisations, e.g. British
Heart Foundation– Mobile units run by occupational healthcare
providers– Health club/Gyms, e.g. Nuffield Health and Wellbeing
Centres (formerly Cannons Health Clubs)
37
Step 4 – Meet the PCT
• Requires good preparation and presentation
• Agree your objectives before the meeting
• Opportunity to clarify issues
• Sell the benefits of pharmacy! (Access, choice, reducing health inequalities)
• Template PowerPoint presentation includes key points
38
Step 5 - Local Service Specification
• NHS Primary Care Contracting Primary Care Framework • PSNC service specification• Other examples on services database• Customisation of service specifications to meet local
needs may include:– prioritisation of the targeting of certain population groups;– local social marketing provisions;– defining equipment standards; and– service monitoring requirements and criteria concerning
outcomes measures
39
Step 6 - Generating local support
• If necessary, try to establish the reasons for non-inclusion of pharmacy contractors in the PCT plans
• Discuss the value of a pharmacy service with key individuals at the PCT (and PBC groups if active in your area), including the Chairman, CEO, Director of Public Health and PEC members
• Talk to the SHA• Brief local councillors / Local Authority health
overview and scrutiny committee on the pharmacy proposals
40
Step 6 - Generating local support
• Brief the local MP on the proposals• Talk to the LMC and influential local GPs - discuss
interface issues, e.g. data transfer protocols and QOF issues
• Work with local patient groups and charities to raise the profile of pharmacy and VRA services
• Undertake an assessment of the public’s views on the best location for VRA using a questionnaire (template questionnaire)
41
Step 7 – Obtaining local health data
• PCT websites• Annual report of the Director of Public Health• www.healthprofiles.info• www.neigbourhood.statistics.gov.uk• DH vascular checks toolkit for PCTs
42
Step 8 - Preparing the bid• Use the local business case / plan template• Establishing the need based on local data and
PCT requirements– Pharmaceutical needs assessment– Wider service assessments– PCT and national targets– PCT underperformance– Patient demand
• Selling the benefits of pharmacy – providing solutions not problems– Use existing service examples and key selling points
43
Elements of a successful business plan
A business plan should clearly identify:• The reasons for the service• Potential risks• Expected clinical outcomes• Improvement in patient care• Benefits for the commissioners
44
Elements of a successful business plan
Detail to be included:• Contact details• Outline of proposed new service or
change• Target population or patient group
including numbers• Patient benefit/anticipated health gains• Evidence base for clinical effectiveness
45
Elements of a successful business plan
• Patient support – consultation?• Stakeholder support – consultation?• Estimated cost implications• Estimated freed up resources and timescales• Links and impact on national or local
objectives• Clinical governance and quality
arrangements• Risk assessment
46
Table discussion
Table 1- How do we engage with stakeholders and integrate the pharmacy service with GPs?
Table 2- How do we overcome commissioner objections?
Table 3 - How do we get and maintain contractor buy in?